Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

You’ve seen the headlines. Now let’s break them open. Sasha-Ann Simons connects you with the people behind the stories: experts, neighbors and newsmakers who shape the city we share. It’s news, ...